RxDoctor Payments Data

Steven Bielamowicz, MD

Otolaryngology · Washington, DCNPI 1164431953

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Integra Lifesciences Corporation at 31.5% of the total. That places this record below the midpoint for otolaryngology clinicians in DC, where the typical reported total is $795.

$795in general payments, 2019–2025

Across 17 payments — averaging $46.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$250
  • Intersect ENT, Inc.$147
  • Inspire Medical Systems, Inc.$139
  • Johnson & Johnson$70
  • Regeneron Healthcare Solutions, Inc.$67
  • Merck$28
  • plus $94 from 4 others

What the payments were for

  • Food & beverage$795100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$795 in reported general payments places this provider in the 50th percentile of 41 otolaryngology providers in District of Columbia.

See all otolaryngology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$132,731
Medicare patients
206
Services billed
2,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate HfaFluticasone Propionate12$4,362
Pantoprazole Sodium133$1,856
Esomeprazole Magnesium18$686
Omeprazole16$385
Alprazolam12$213
Amitriptyline Hcl22$202
Famotidine35$198
Gabapentin12$150
Propranolol Hcl11$132
Nortriptyline Hcl11$76

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →